BOTOX Treatment in Pediatric Upper Limb Spasticity: Double-blind Study
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Muscle spasticity
- Focus Registrational; Therapeutic Use
- Sponsors Allergan
- 01 Sep 2017 Status changed from recruiting to completed.
- 12 Sep 2016 Planned number of patients changed from 412 to 224.
- 10 Jun 2015 Planned End Date changed from 1 May 2015 to 1 May 2017 as reported by ClinicalTrials.gov record.